3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Hepatocellular
8
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Liver Neoplasms
3
Stomach Neoplasms
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Squamous Cell
2
Urothelial Cancer
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Solid Malignancies
1
Seminoma
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Nonseminomatous germ cell tumor
1
Non Small Cell Lung Cancer NSCLC
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Neoplasm Metastasis
1
Microsatellite Instability
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Mesothelioma, Malignant
1
Lung Cancer Metastatic
1
Immunotherapy
1
Hydronephrosis
1
Interventions
pembrolizumab
34
Specimen Handling
18
Paclitaxel
16
Magnetic Resonance Spectroscopy
15
Carboplatin
14
Biopsy
14
Nivolumab
13
Ipilimumab
12
Gemcitabine
10
Irinotecan
9
Radiosurgery
8
atezolizumab
7
abemaciclib
7
Radiation
7
Pemetrexed
7
Cisplatin
7
Capecitabine
7
130-nm albumin-bound paclitaxel
7
trastuzumab deruxtecan
6
olaparib
6
durvalumab
6
avelumab
6
Docetaxel
6
osimertinib
5
adagrasib
5
Trastuzumab
5
Fulvestrant
5
Cetuximab
5
Albumin-Bound Paclitaxel
5
palbociclib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neoplasm Metastasis
×
tremelimumab
×
Clear all
NCT05000710
2024-12-05
CORAL-Lung
Sheba Medical Center
Phase 2
Active not recruiting
29 enrolled